Stryker Q4 adjusted EPS up 15.9% to $4.01, organic sales +10.2%; guides 2025 8-9% growth

STRYKER CORP

2024-FY EPS reported $7.76 revenue$22,595,000,000

Reported EPS fell 52.7% to $1.41 due to $818M goodwill/impairment charges on Spine; adjusted EPS rose 15.9% to $4.01.
Organic net sales increased 10.2% in Q4 and full year 2024, driven by 9.1% volume growth and 1.1% price.
Full-year adjusted operating margin expanded 110 bps to 25.3%; reported operating margin was 16.3%.
2025 guidance: organic sales growth 8-9%, adjusted EPS $13.45-$13.70; Inari acquisition expected to close late Feb with ~$590M stub sales.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.